Parschauer Karah Herdman 4

What Happened
Parschauer Karah Herdman, a director of Tenaya Therapeutics (TNYA), received an award of 120,000 derivative securities on 2026-05-28. The Form 4 reports the grant at $0.00 (no cash exchanged at grant). This is an equity compensation award (grant of options or similar) rather than a market purchase or sale.

Key Details

• Transaction date: 2026-05-28; Form 4 filed 2026-05-29 (timely filing).
• Reported transaction: Award/Grant (code A) of 120,000 derivative shares; price shown $0.00.
• Shares owned after transaction: Not specified in the provided excerpt of the filing.
• Footnote: The option was granted under the Amended and Restated Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan and will vest in full on May 28, 2027, or, if earlier, the day immediately before the next annual stockholder meeting after the grant date, subject to continued service.
• No indication in this filing that shares were exercised or sold immediately (this was a grant only).

Context

• Director equity grants are common as part of compensation and do not by themselves indicate a director buying or selling stock in the open market.
• As a derivative award (option/award), value is realized only if and when the option vests and is exercised; tax and economic impact depend on future exercise and any subsequent sale.
• If you track insider activity for investment signals, grants are informative about compensation alignment but are generally less directly bullish than open-market purchases.